scispace - formally typeset
Search or ask a question
Institution

University of Milano-Bicocca

EducationMilan, Italy
About: University of Milano-Bicocca is a education organization based out in Milan, Italy. It is known for research contribution in the topics: Population & Blood pressure. The organization has 8972 authors who have published 22322 publications receiving 620484 citations. The organization is also known as: Università degli Studi di Milano-Bicocca & Universita degli Studi di Milano-Bicocca.


Papers
More filters
Journal ArticleDOI
TL;DR: Cationic polymers could overcome the surfactant barrier which inhibited airway cell transfection mediated by cationic lipids and give similar levels of lung luciferase expression by targeting differentAirway cell populations.
Abstract: Biodistribution of nonviral cationic vector/DNA complexes was studied after systemic or intratracheal administration to the lungs and correlated with transgene expression. Intravenous injection in C57Bl/6 mice gave maximal and significant luciferase expression in the lungs with the cationic polymer PEI 22K/DNA complexes at the highest ratios of positive/negative charges versus DNA alone. While DOTAP/DNA complexes with high charge ratio determined lower but still significant luciferase activity versus uncomplexed DNA, GL-67A and PEI 25K mediated negligible luciferase expression. Labelled PEI 22K and DOTAP complexes were evenly distributed in the alveolar region, where GFP expression was revealed, while PEI 25K and GL-67A complexes were not detected, suggesting a different interaction of these complexes with the plasma membrane of endothelial cells. Following an intratracheal injection, the highest and significant levels of transfection were obtained with slightly positive PEI complexes as compared with DNA alone, whereas cationic lipid-based vectors, DOTAP and GL-67A, gave not significant luciferase activity. Both types of polyplexes gave similar levels of lung luciferase expression by targeting different airway cell populations. PEI 25K complexes determined high levels of GFP in the bronchial cells, confirming confocal data on fluorescent complexes internalization. PEI 22K complexes gave mainly high GFP signal in the distal tract of the bronchial tree, where tagged complexes were recovered. Fluorescent lipid complexes were found in aggregates in the lumen of bronchi totally (DOTAP) or partially (GL-67A) co-localizing with surfactant protein A. Results indicated that cationic polymers could overcome the surfactant barrier which inhibited airway cell transfection mediated by cationic lipids.

141 citations

Journal ArticleDOI
Livio Pagano1, Livio Pagano2, Jon Salmanton-García3, Francesco Marchesi, Alessandro Busca, Paolo Corradini4, Martin Hoenigl5, Martin Hoenigl6, Nikolai Klimko, Philipp Koehler3, Antonio Pagliuca7, Francesco Passamonti8, Luisa Verga9, Benjamin Víšek, Osman Ilhan10, Gianpaolo Nadali, Barbora Weinbergerova11, Raúl Córdoba-Mascuñano, Monia Marchetti, Graham P. Collins12, Francesca Farina, Chiara Cattaneo, Alba Cabirta13, Maria Gomes-Silva, Federico Itri, Jaap van Doesum14, Marie-Pierre Ledoux, Martin Čerňan15, Ozren Jakšić, Rafael F. Duarte, Gabriele Magliano, Ali S. Omrani16, Nicola Stefano Fracchiolla17, Austin G. Kulasekararaj7, Austin G. Kulasekararaj18, Toni Valković19, Christian Bjørn Poulsen, Marina Machado20, Andreas Glenthøj, Igor Stoma21, Zdeněk Ráčil, Klára Piukovics22, Milan Navrátil, Ziad Emarah23, Uluhan Sili24, Johan Maertens25, Ola Blennow26, Rui Bergantim, Carolina García-Vidal, Lucia Prezioso, Anna Guidetti, Maria Ilaria Del Principe27, Marina Popova, Nick de Jonge28, Irati Ormazabal-Vélez, Noemí Fernández, Iker Falces-Romero29, Annarosa Cuccaro, Stef Meers, Caterina Buquicchio, Darko Antic30, Murtadha Al-Khabori31, Ramón García-Sanz32, Monika Biernat33, Maria Chiara Tisi, Ertan Sal3, Laman Rahimli3, Natasa Colovic30, Martin Schönlein34, Maria Calbacho, Carlo Tascini, Carolina Miranda-Castillo, Nina Khanna35, Gustavo-Adolfo Méndez, Verena Petzer36, Jan Novák, Caroline Besson, Rémy Duléry37, Sylvain Lamure38, Marcio Nucci39, Giovanni Zambrotta9, Pavel Žák, Guldane Cengiz Seval10, Valentina Bonuomo, Jiří Mayer11, Alberto López-García, Maria Vittoria Sacchi, Stephen Booth12, Fabio Ciceri, Margherita Oberti, Marco Salvini8, Macarena Izuzquiza13, Raquel Nunes-Rodrigues, Emanuele Ammatuna14, Aleš Obr15, Raoul Herbrecht, Lucía Núñez-Martín-Buitrago, Valentina Mancini, Hawraa M Shwaylia16, Mariarita Sciumè17, Jenna Essame7, Marietta Nygaard, Josip Batinić40, Josip Batinić41, Yung Gonzaga, Isabel Regalado-Artamendi20, Linda Katharina Karlsson, Maryia Shapetska, Michaela Hanakova, Shaimaa El-Ashwah23, Zita Borbényi22, Gökçe Melis Çolak24, Anna Nordlander26, Giulia Dragonetti1, Giulia Dragonetti2, Alessio Maria Edoardo Maraglino1, Alessio Maria Edoardo Maraglino2, Amelia Rinaldi, Cristina De Ramón-Sánchez32, Oliver A Cornely 
TL;DR: In this paper, the authors studied the risk factors for adverse outcomes in patients with hematological malignancies (HM) who developed COVID-19 and analyzed predictors of mortality.
Abstract: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. We therefore studied baseline characteristics of HM patients developing COVID-19 and analyzed predictors of mortality. The survey was supported by the Scientific Working Group Infection in Hematology of the European Hematology Association (EHA). Eligible for the analysis were adult patients with HM and laboratory-confirmed COVID-19 observed between March and December 2020. The study sample includes 3801 cases, represented by lymphoproliferative (mainly non-Hodgkin lymphoma n = 1084, myeloma n = 684 and chronic lymphoid leukemia n = 474) and myeloproliferative malignancies (mainly acute myeloid leukemia n = 497 and myelodysplastic syndromes n = 279). Severe/critical COVID-19 was observed in 63.8% of patients (n = 2425). Overall, 2778 (73.1%) of the patients were hospitalized, 689 (18.1%) of whom were admitted to intensive care units (ICUs). Overall, 1185 patients (31.2%) died. The primary cause of death was COVID-19 in 688 patients (58.1%), HM in 173 patients (14.6%), and a combination of both COVID-19 and progressing HM in 155 patients (13.1%). Highest mortality was observed in acute myeloid leukemia (199/497, 40%) and myelodysplastic syndromes (118/279, 42.3%). The mortality rate significantly decreased between the first COVID-19 wave (March–May 2020) and the second wave (October–December 2020) (581/1427, 40.7% vs. 439/1773, 24.8%, p value < 0.0001). In the multivariable analysis, age, active malignancy, chronic cardiac disease, liver disease, renal impairment, smoking history, and ICU stay correlated with mortality. Acute myeloid leukemia was a higher mortality risk than lymphoproliferative diseases. This survey confirms that COVID-19 patients with HM are at high risk of lethal complications. However, improved COVID-19 prevention has reduced mortality despite an increase in the number of reported cases.

141 citations

Journal ArticleDOI
04 Sep 2003-Oncogene
TL;DR: In this paper, the authors investigated whether the receptors located inside and outside cave-olar microdomains initiate different signalling pathways and how this may lead to opposite effects on cell proliferation.
Abstract: We have recently shown that oxytocin inhibits cell proliferation when the vast majority of oxytocin receptors are excluded from caveolin-1-enriched microdomains, and that, on the contrary, it has a mitogenic effect when the receptors are targeted to these plasma membrane domains. In this study, we investigated whether the receptors located inside and outside caveolar microdomains initiate different signalling pathways and how this may lead to opposite effects on cell proliferation. Our data indicate that, depending on their localization, oxytocin receptors transactivate EGFR and activate ERK1/2 using different signalling intermediates. The final outcome is a different temporal pattern of EGFR and ERK1/2 phosphorylation, which is more persistent when the receptors are located outside caveolar microdomains and inhibit cell growth, and very transient when they are located in caveolar microdomains and stimulate cell growth. Finally, only the activation of receptors located outside caveolar microdomains correlates with the activation of the cell cycle inhibitor p21(WAF1/CIP1), thus suggesting that the antiproliferative OTR effects may, in this case, be achieved by a sustained activation of EGFR and MAPK leading to the induction of this cell cycle regulator.

141 citations

Journal ArticleDOI
TL;DR: The longer spacer of glycines, the more effective is the functional motif in both eliciting NSCs adhesion, improving their viability and increasing their differentiation.
Abstract: The understanding of phenomena involved in the self-assembling of bio-inspired biomaterials acting as three-dimensional scaffolds for regenerative medicine applications is a necessary step to develop effective therapies in neural tissue engineering. We investigated the self-assembled nanostructures of functionalized peptides featuring four, two or no glycine-spacers between the self-assembly sequence RADA16-I and the functional biological motif PFSSTKT. The effectiveness of their biological functionalization was assessed via in vitro experiments with neural stem cells and their molecular assembly was elucidated via atomic force microscopy, Raman and FTIR spectroscopy. We demonstrated that glycine-spacers play a crucial role in the scaffold stability and in the exposure of the functional motifs. In particular, a glycine-spacer of four residues leads to a more stable nanostructure and to an improved exposure of the functional motif. Accordingly, the longer spacer of glycines, the more effective is the functional motif in both eliciting neural stem cells adhesion, improving their viability and increasing their differentiation. Therefore, optimized designing strategies of functionalized biomaterials may open, in the near future, new therapies in tissue engineering and regenerative medicine.

141 citations

Journal ArticleDOI
TL;DR: The risk model can use non-HLA risk factors for CD to improve identification of high-risk individuals with slight decrease in specificity and is a first step toward better diagnosis and prognosis in high- risk families and population-based screening.

141 citations


Authors

Showing all 9226 results

NameH-indexPapersCitations
Carlo Rovelli1461502103550
Giuseppe Mancia1451369139692
Marco Bersanelli142526105135
Teruki Kamon1422034115633
Marco Colonna13951271166
M. I. Martínez134125179885
A. Mennella13246393236
Roberto Salerno132119783409
Federico Ferri132137689337
Marco Paganoni132143888482
Arabella Martelli131131884029
Sandra Malvezzi129132684401
Andrea Massironi129111578457
Marco Pieri129128582914
Cristina Riccardi129162791452
Network Information
Related Institutions (5)
Sapienza University of Rome
155.4K papers, 4.3M citations

97% related

University of Bologna
115.1K papers, 3.4M citations

96% related

University of Padua
114.8K papers, 3.6M citations

96% related

University of Milan
139.7K papers, 4.6M citations

96% related

VU University Amsterdam
75.6K papers, 3.4M citations

95% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023173
2022349
20212,468
20202,253
20191,905
20181,706